Insider Stock Trading History of Ertel Steven D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ertel Steven D since year 2005. The trader's CIK number is 1586752. At the time of this reporting, Ertel Steven D is the EVP & Chief Operating Officer of Acceleron Pharma Inc . (stock ticker symbol XLRN). See this page for all insider trading activities at Acceleron Pharma Inc .


Stock purchases, sales, and option exercises reported by insider Ertel Steven D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-04 XLRN Acceleron Pharma Inc Sale 2,500 27.27 68,162
2016-07-07 XLRN Acceleron Pharma Inc Option Ex 4,421 5.28 23,342
2016-07-05 XLRN Acceleron Pharma Inc Option Ex 3,966 5.28 20,940
2016-07-05 XLRN Acceleron Pharma Inc Sale 3,966 33.51 132,900
2016-07-01 XLRN Acceleron Pharma Inc Option Ex 28,304 4.58 129,632
2016-07-01 XLRN Acceleron Pharma Inc Sale 28,304 34.77 984,130
2016-04-07 XLRN Acceleron Pharma Inc Sale 32,270 32.00 1,032,640
2016-04-07 XLRN Acceleron Pharma Inc Option Ex 32,270 5.34 172,321
2015-09-15 XLRN Acceleron Pharma Inc Sale 2,000 33.61 67,220
2015-09-15 XLRN Acceleron Pharma Inc Option Ex 2,000 5.28 10,560
2015-08-17 XLRN Acceleron Pharma Inc Option Ex 2,000 5.28 10,560
2015-08-17 XLRN Acceleron Pharma Inc Sale 2,000 30.46 60,920
2015-07-15 XLRN Acceleron Pharma Inc Sale 2,000 31.38 62,760
2015-07-15 XLRN Acceleron Pharma Inc Option Ex 2,000 4.58 9,160
2015-06-15 XLRN Acceleron Pharma Inc Option Ex 2,000 3.88 7,760
2015-06-15 XLRN Acceleron Pharma Inc Sale 2,000 31.11 62,220
2015-05-15 XLRN Acceleron Pharma Inc Option Ex 2,000 3.88 7,760
2015-05-15 XLRN Acceleron Pharma Inc Sale 2,000 31.45 62,910
2015-05-08 XLRN Acceleron Pharma Inc Option Ex 5,000 3.88 19,400
2015-04-15 XLRN Acceleron Pharma Inc Option Ex 2,000 3.88 7,760
2015-04-15 XLRN Acceleron Pharma Inc Sale 2,000 33.58 67,160
2015-03-04 XLRN Acceleron Pharma Inc Option Ex 5,000 3.44 17,200
2015-03-04 XLRN Acceleron Pharma Inc Sale 5,000 41.29 206,450
2015-02-02 XLRN Acceleron Pharma Inc Sale 5,000 39.10 195,515
2015-02-02 XLRN Acceleron Pharma Inc Option Ex 5,000 1.80 9,000
2015-01-15 XLRN Acceleron Pharma Inc Option Ex 2,000 3.88 7,760
2015-01-15 XLRN Acceleron Pharma Inc Sale 2,000 40.79 81,580
2015-01-02 XLRN Acceleron Pharma Inc Option Ex 5,000 1.80 9,000
2015-01-02 XLRN Acceleron Pharma Inc Sale 5,000 38.84 194,200
2014-12-01 XLRN Acceleron Pharma Inc Sale 7,500 36.16 271,177
2014-12-01 XLRN Acceleron Pharma Inc Option Ex 7,500 2.60 19,500
2014-11-12 XLRN Acceleron Pharma Inc Option Ex 10,000 2.31 23,070
2014-11-12 XLRN Acceleron Pharma Inc Sale 10,000 33.04 330,379
2014-10-01 XLRN Acceleron Pharma Inc Sale 10,000 29.90 299,030
2014-10-01 XLRN Acceleron Pharma Inc Option Ex 10,000 2.13 21,330
2014-09-02 XLRN Acceleron Pharma Inc Sale 10,000 26.43 264,350
2014-09-02 XLRN Acceleron Pharma Inc Option Ex 10,000 2.74 27,400
2014-08-25 XLRN Acceleron Pharma Inc Option Ex 9,000 3.88 34,920
2014-08-14 XLRN Acceleron Pharma Inc Option Ex 10,000 2.74 27,400
2014-08-14 XLRN Acceleron Pharma Inc Sale 10,000 29.97 299,730
2014-07-30 XLRN Acceleron Pharma Inc Option Ex 8,000 3.88 31,040
2014-07-01 XLRN Acceleron Pharma Inc Option Ex 10,000 2.74 27,400
2014-07-01 XLRN Acceleron Pharma Inc Sale 10,000 34.09 340,950
2014-06-17 XLRN Acceleron Pharma Inc Option Ex 8,000 3.88 31,040
2014-06-02 XLRN Acceleron Pharma Inc Sale 10,000 29.83 298,270
2014-06-02 XLRN Acceleron Pharma Inc Option Ex 10,000 2.74 27,400
2014-05-19 XLRN Acceleron Pharma Inc Option Ex 10,000 2.74 27,400
2014-05-19 XLRN Acceleron Pharma Inc Sale 10,000 31.88 318,780
2014-04-22 XLRN Acceleron Pharma Inc Option Ex 2,500 .40 1,000
2014-04-22 XLRN Acceleron Pharma Inc Sale 2,500 35.96 89,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ertel Steven D (EVP & Chief Operating Officer of Acceleron Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.